A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD
ACTIVE_NOT_RECRUITING
Status
Conditions
- Pulmonary Arterial Hypertension
- Pulmonary Hypertension Due to Lung Diseases
Interventions
- COMBINATION_PRODUCT: L606 inhalation suspension
Sponsor
Liquidia Technologies, Inc.
Collaborators